`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`_____________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________
`
`MICRO LABS LIMITED AND MICRO LABS USA INC.
`Petitioners,
`
`v.
`
`SANTEN PHARMACEUTICAL CO., LTD. AND ASAHI GLASS CO., LTD.
`Patent Owners.
`_____________
`
`Inter Partes Review No. IPR2017-01434
`U.S. Patent No. 5,886,035
`
`_____________
`
`
`PETITIONERS’ UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`
`
`
`
`In accordance with the Patent Trial and Appeal Board’s November 29, 2017 Order (Paper
`
`No. 11), pp. 5–6, n.1, n.2, Petitioners submit two new exhibits, Ex. 1029 and Ex. 1030.
`
`The content of Exhibit 1029 is the same as Ex. 1006 (“Ueno”), except for the addition of
`
`two new declarations at the end in compliance with 37 C.F.R. §§ 1.68 and 42.63(b). One
`
`declaration is sworn by the same person who submitted the original certification, Hannah
`
`Mendoza, the project manager for the translation. The second declaration is sworn by a member
`
`of the translation team personally attesting to the accuracy of the translation, Frank McGee.
`
`The content of Exhibit 1030 is the same as Ex. 1007 (“Bezuglov 1982”), except for the
`
`addition of two new declarations at the end in compliance with 37 C.F.R. §§ 1.68 and 42.63(b).
`
`One declaration is sworn by the same person who submitted the original certification, Sarah
`
`Faup (whose last name has since become Hall), the project manager for the translation. The
`
`second declaration is sworn by a member of the translation team personally attesting to the
`
`accuracy of the translation, Keith Blasing.
`
`Petitioners provide an updated exhibit list below:
`
`PETITIONERS’ UPDATED EXHIBIT LIST
`
`Exhibit No.
`
`Document
`
`1001
`
`U.S. Patent No. 5,886,035 to Shirasawa et al. (issued March 23, 1999).
`
`1002
`
`File History of U.S. Patent No. 5,886,035.
`
`1003
`
`1004
`
`EP0639563A2 to Klimko et al. (published February 22, 1995).
`
`EP0471856A1 to Kishi et al. (published February 26, 1992).
`
`1005
`
`U.S. Patent No. 5,292,754 to Kishi et al. (issued March 8, 1994).
`
`1006
`
`JP-A-7070054 to Ueno Japan et al. (published March 14, 1995).
`
`2
`
`
`
`
`
`1007
`
`1008
`
`1009
`
`1010
`
`Bezuglov, V. V. & L. D. Bergelson, “Fluoroprostaglandins—A New Class of
`Biologically Active Analogues of Natural Prostaglandins” in Lipids of
`Biological Membranes (L.D. Bergelson, ed., 1982).
`
`Bezuglov, Vladimir V. “Fluorodeoxy Prostaglandins, Synthesis and
`Perspectives” in Prostaglandins and Cardiovascular Diseases (Takayuki Ozawa
`et al. eds., 1986).
`
`Camras et al. “Reduction of intraocular pressure in normal and glaucomatous
`primate (Aotus trivirgatus) eyes by topically applied PGF2 ,” Curr. Eye Res.
`1:205-209 (1981).
`
`Stjernschantz, J.W. “From PGF2 -Isopropyl Ester to Latanoprost: A Review
`of the Development of Xalatan,” Investig. Ophthal. & Vis. Sci. 42(6):1134-
`1145 (2001).
`
`1011
`
`Nixon, D. “Hyperemia in Glaucoma Patients,” (2008) available online at
`http://www.medscape.org/viewarticle/577054.
`
`1012
`
`PCT/US97/20671 to Klimko et al. (published May 22, 1998).
`
`1013
`
`U.S. Provisional Patent Application No. 60/030,519 to Klimko et al. (made
`accessible as of May 22, 1998).
`
`1014
`
`Alm A 1989 Progress in Clin and Biological Research pg 447-458.
`
`1015
`
`Stjernschantz J 1992 Drugs of the Future 691-704.
`
`1016
`
`1017
`
`1018
`
`1019
`
`Product Details for NDA 020597 (XALATAN) available online at
`https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Typ
`e=N&Appl_No=020597.
`
`Patent and Exclusivity for: N202514 (ZIOPTAN) available online at
`https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=0
`01&Appl_No=202514&Appl_type=N.
`
`Lee, P.Y. et al., “The effect of prostaglandin F2 alpha on intraocular pressure in
`normotensive human subjects,” Invest. Ophthalmol. Vis. Sci. Oct.
`29(10):1474–1477 (1988).
`
`Camras, C.B. et al., “Maintained reduction of intraocular pressure by
`prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular
`hypertensive and glaucoma patients,” Ophthalmology Sep. 96(9):1329–1337
`(1989).
`
`3
`
`
`
`
`
`1020
`
`1021
`
`1022
`
`1023
`
`1024
`
`Nilsson, S.F. et al., “Increased uveoscleral outflow as a possible mechanism of
`ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the
`cynomolgus monkey,” Exp. Eye Res. May 48(5):707–716 (1989).
`
`Pederson, J.E. et al., “Laser-induced primate glaucoma. I. Progression of
`cupping,” Arch. Ophthalmol. Nov. 102(11):1689-92 (1984).
`
`Radius, R.L. et al., “Laser-induced primate glaucoma. II. Histopathology,”
`Arch. Ophthalmol. Nov. 102(11):1693-8 (1984).
`
`Lee, P.Y. et al., “Pharmacological testing in the laser-induced monkey
`glaucoma model,” Curr. Eye Res. Jul. 4(7):775-81 (1985).
`
`Bito, L.Z. “Species differences in the responses of the eye to irritation and
`trauma: a hypothesis of divergence in ocular defense mechanisms, and the
`choice of experimental animals for eye research,” Exp. Eye Res. Dec.
`39(6):807-29 (1984).
`
`1025
`
`U.S. Patent No. 3,914,265 to Middleton (issued October 21, 1975).
`
`1026
`
`Nelson, N.A. “Prostaglandin Nomenclature,” J. Med. Chem. 17(9):911-918
`(1974).
`
`1027
`
`Declaration of Mitchel deLong, Ph.D
`
`1028
`
`Declaration of Aron D. Rose, M.D.
`
`1029
`
`1030
`
`Exhibit 1006 (JP-A-7070054 to Ueno Japan et al. (published March 14, 1995)
`(“Ueno”)) with affidavits in compliance with 37 C.F.R. §§ 42.63(b) and 1.68,
`as required by the Board in its November 29, 2017 Order (Paper No. 11), pp. 5–
`6, n.1.
`
`Exhibit 1007 (Bezuglov, V. V. & L. D. Bergelson, “Fluoroprostaglandins—A
`New Class of Biologically Active Analogues of Natural Prostaglandins” in
`Lipids of Biological Membranes (L.D. Bergelson, ed., 1982) (“Bezuglov
`1982”)) with affidavits in compliance with 37 C.F.R. §§ 42.63(b) and 1.68, as
`required by the Board in its November 29, 2017 Order (Paper No. 11), p. 6, n.2.
`
`
`
`
`
`
`
`
`
`
`4
`
`
`
`
`
`Dated: December 11, 2017
`
`
`
`
`
`By: /Cedric C.Y. Tan/
` Cedric C.Y. Tan (Reg. No. 56,082)
`Sean M. Weinman (Reg. No. 69,515)
`PILLSBURY WINTHROP
`SHAW PITTMAN LLP
`1200 Seventeenth Street, NW
`Washington, DC 20036
`Tel.: (202) 663-8000
`Fax.: (202) 663-8007
`Email: cedric.tan@pillsburylaw.com
`
`
`5
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a true copy of the foregoing Petitioners’ Updated
`
`Exhibit List was served on December 11, 2017, by filing this document through the Patent Trial
`
`and Appeal Board End to End System as well as delivering a copy via electronic mail upon the
`
`following attorneys of record for Patent Owner:
`
`
`
`
`
`
`
`
`
`
`Arlene L. Chow (Reg. No. 47,489)
`arlene.chow@hoganlovells.com
`Eric J. Lobenfeld (pro hac vice)
`eric.lobenfeld@hoganlovells.com
`Ernest Yakob, Ph.D. (Reg. No. 45,893)
`ernest.yakob@hoganlovells.com
`HOGAN LOVELLS US LLP
`875 Third Avenue
`New York, NY 10022
`Tel: (212) 918-3000
`Fax: (212) 918-3100
`
`
` /Cedric C.Y. Tan/
` Cedric C.Y. Tan (Reg. No. 56,082)
`PILLSBURY WINTHROP
`SHAW PITTMAN LLP
`1200 Seventeenth Street, NW
`Washington, DC 20036
`Tel.: (202) 663-8000
`Fax.: (202) 663-8007
`Email: cedric.tan@pillsburylaw.com
`
`
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
